IJMS | Free Full-Text | Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica
Thalassaemia - The Lancet
Full article: Revisiting beta thalassemia intermedia: past, present, and future prospects
Replacing the suppressed hormone: toward a better treatment for iron overload in β-thalassemia major? | Haematologica
Significance of genetic modifiers of hemoglobinopathies leading towards precision medicine | Scientific Reports
An urgent need for improving thalassemia care due to the wide gap in current real-life practice and clinical practice guidelines | Scientific Reports
Current and future alternative therapies for beta-thalassemia major - ScienceDirect
Antioxidants as Complementary Medication in Thalassemia | IntechOpen
Beta Thalassemia: Practice Essentials, Etiology, Epidemiology
Non-transfusion-dependent thalassemias | Haematologica
Β-Thalassemias | NEJM
2021 update on clinical trials in β‐thalassemia - Musallam - 2021 - American Journal of Hematology - Wiley Online Library
Pathophysiology and treatment of patients with... | F1000Research
PDF) Selecting β-thalassemia Patients for Gene Therapy: A Decision-making Algorithm
Cureus | Thalassemia: A Review of the Challenges to the Families and Caregivers
New treatment strategies for β-thalassemia | Encyclopedia MDPI
Novel genetic therapeutic approaches for modulating the severity of β‑ thalassemia (Review)
Tricuspid-valve regurgitant jet velocity as a risk factor for death in β- thalassemia | Haematologica
Advances in genome editing: the technology of choice for precise and efficient β-thalassemia treatment | Gene Therapy
